Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC642781 Inhibitors

The classification of LOC642781 Inhibitors refers to a specialized category of chemical compounds designed to modulate the activity of LOC642781, a molecular target currently subject to scientific investigation. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, emphasizing their capacity to selectively interfere with the normal functions of LOC642781 within cellular processes. The structural features of LOC642781 Inhibitors undergo a rigorous optimization process, involving computational modeling and structure-activity relationship studies, to ensure their molecular configurations are precisely tailored for effective binding to the target.

The significance of LOC642781 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC642781, a molecular entity presumed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC642781 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC642781 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC642781 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC642781 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram selectively inhibits PDE4, increasing cAMP levels in cells. It has been studied for its potential antidepressant and anti-inflammatory effects.

Roflumilast

162401-32-3sc-208313
5 mg
$60.00
21
(1)

Roflumilast is a selective, long-acting inhibitor of PDE4 with anti-inflammatory properties.

Apremilast

608141-41-9sc-480062
5 mg
$444.00
(0)

Apremilast is a selective PDE4 inhibitor that modulates inflammatory pathways by increasing cAMP levels.

Piclamilast

144035-83-6sc-478653
5 mg
$300.00
(0)

Piclamilast is a potent and selective PDE4 inhibitor that may have anti-inflammatory and immunomodulatory effects.

Luteolin

491-70-3sc-203119
sc-203119A
sc-203119B
sc-203119C
sc-203119D
5 mg
50 mg
500 mg
5 g
500 g
$27.00
$51.00
$101.00
$153.00
$1925.00
40
(1)

Luteolin is a flavonoid that has been shown to inhibit PDE4 among other targets, with potential anti-inflammatory effects.

Ibudilast

50847-11-5sc-203080
10 mg
$218.00
1
(1)

Ibudilast is a non-selective PDE inhibitor with activity against PDE4.

Zardaverine

101975-10-4sc-201208
sc-201208A
5 mg
25 mg
$88.00
$379.00
1
(0)

Zardaverine is a dual PDE3/PDE4 inhibitor that can raise cAMP levels and has been studied for its bronchodilatory properties.